These codes apply to services from October 1, 2025 through September 30, 2026 under the FY2026 ICD-10-CM release
While some plans may cover these medications for diabetes management, coverage for weight loss alone is far less common
(GLP-1 drugs mimic a hormone produced in the gut to tamp down a person's appetite and regulate their blood sugar.) This means that drugs like Eli Lilly's Mounjaro, which is used to treat diabetes, and Zepbound, which is used for weight loss, can now keep up with current demand
Bimetallic nanoconjugate hijack Fe-S clusters to drive a closed-loop cuproptosis-ferroptosis strategy for osteosarcoma inhibition
Cyanocobalamin is excreted in human breast milk in safe concentrations
Can overdosing on semaglutide be fatal